← Back to Patent Explorer
US5059608A Expired / Lapsed US ⏱️ 0.0 years remaining

Bicyclic amine compound and a process for the preparation thereof

Assignee: Astellas Pharma Inc
•
Filing: 1989-03-23
•
Granted: 1991-10-22
•
Expires: 2009-03-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to a compound useful as an anticonvulsant, and for treatment of delayed neuronal death, the compound being a bicyclic amine of the formula: <IMAGE> wherein R1 is lower alkyl, R2 is aryl which may have one or more suitable substituent(s), cyclo(lower)alkyl or heterocyclic group, R3 is hydrogen, lower alkyl which may have one or more suitable substituent(s), lower alkenyl, or acyl which may have one or more suitable substituent(s), R4 is hydrogen, lower alkyl, or hydroxy(lower)alkyl, R5 is hydrogen, lower alkyl, halogen, or protected amino, and n is an integer of 1 or 2, with the proviso that when R3 is lower alkyl which may have one or more suitable substituent(s), R2 is cyclo(lower)alkyl or heterocyclic group, or a pharmaceutically acceptable salt thereof.

Inventors

  • 👤 Hisashi Takasugi
  • 👤 Atsushi Kuno
  • 👤 Mitsuru Ohkubo

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 20:04
CPC Classifications
C; C07; C07D; C07D223/00; C07D223/14; C07D223/16; A; A61; A61P; A61P25/00; A61P25/08; C07D217/00; C07D217/02; C07D217/04; C07D217/06; C07D217/12; C07D217/14; C07D217/16; C07D405/00; C07D405/02; C07D405/04; C07D409/00; C07D409/02; C07D409/04; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 114 words
A bicyclic amine compound of the formula: ##STR5## wherein R 1 is lower alkyl, R 2 is aryl which may have one or more suitable substituent(s), cyclo(lower)alkyl or heterocyclic group, R 3 is hydrogen, lower alkyl which may have one or more suitable substituent(s), lower alkenyl, or acyl which may have one or more suitable substituent(s), R 4 is hydrogen, lower alkyl, or hydroxy(lower)alkyl, R 5 is hydrogen, lower alkyl, halogen, or protected amino, and n is an integer of 1 or 2, with the proviso that when R 3 is lower alkyl which may have one or more suitable substituent(s), R 2 is cyclo(lower)alkyl or heterocyclic group, or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 114 words
A bicyclic amine compound of the formula: ##STR5## wherein R 1 is lower alkyl, R 2 is aryl which may have one or more suitable substituent(s), cyclo(lower)alkyl or heterocyclic group, R 3 is hydrogen, lower alkyl which may have one or more suitable substituent(s), lower alkenyl, or acyl which may have one or more suitable substituent(s), R 4 is hydrogen, lower alkyl, or hydroxy(lower)alkyl, R 5 is hydrogen, lower alkyl, halogen, or protected amino, and n is an integer of 1 or 2, with the proviso that when R 3 is lower alkyl which may have one or more suitable substituent(s), R 2 is cyclo(lower)alkyl or heterocyclic group, or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 140 words
A compound of claim 1, wherein R 2 is aryl which may have 1 to 3 suitable substituent(s) selected from a group consisting of lower alkyl, lower alkoxy and halogen; cyclo(lower)alkyl or unsaturated 5- or 6-membered heterocyclic group having 1 to 3 oxygen or sulfur atom(s), R 3 is hydrogen, lower alkyl which may have 1 to 3 suitable substituent(s) selected from a group consisting of aryl and cyclic amino; lower alkenyl or acyl which may have 6b 1 to 3 suitable substituent(s) selected from a group consisting of halogen and cyclic amino, with the proviso that when R 3 is lower alkyl which may have 1 to 3 suitable substituent(s) selected from a group consisting of aryl and cyclic amino, R 2 is cyclo(lower)alkyl or unsaturated 5- or 6-membered hetero-cyclic group having 1 to 3 oxygen or sulfur atom(s).
Claim 4
Dependent Claim 140 words
A compound of claim 2, wherein R 2 is phenyl which may have 1 to 3 suitable substituent(s) selected from a group consisting of lower alkyl, lower alkoxy and halogen, cyclo(lower)alkyl or unsaturated 5-membered heterocyclic group having 1 to 2 oxygen or sulfur atoms(s), R 3 is hydrogen, lower alkyl which may have 1 to 3 suitable substituent(s) selected from a group consisting of phenyl and 6-membered cyclic amino; lower alkenyl or lower alkanoyl which may have 6b 1 to 3 suitable substituent(s) selected from a group consisting of halogen and 6-membered cyclic amino, with the proviso that when R 3 is lower alkyl which may have 1 to 3 suitable substituent(s) selected from a group consisting of phenyl and 6-membered cyclic amino, R 2 is cyclo(lower)alkyl or unsaturated 5-membered heterocyclic group having 1 to 2 oxygen or sulfur atom(s).
Claim 5
Dependent Claim 87 words
A compound of claim 3, wherein R 2 is phenyl, phenyl having lower alkyl, phenyl having lower alkoxy, phenyl having halogen, cyclo(lower)alkyl, furyl or thienyl, R 3 is hydrogen, lower alkyl, lower alkyl having phenyl, lower alkyl having piperidino, lower alkenyl, lower alkanaoyl having halogen or lower alkanoyl having piperidino, and R 5 is hydrogen, lower alkyl, halogen or lower alkoxycarbonylamino, with the proviso that when R 3 is lower alkyl, lower alkyl having phenyl or lower alkyl having piperidino, R 2 is cyclo(cyclo)alkyl, furyl or thienyl.
Claim 6
Dependent Claim 12 words
A compound of claim 4, wherein n is an integer of 1.
Claim 7
Dependent Claim 10 words
A compound of claim 5, wherein R 3 is hydrogen.
Claim 8
Dependent Claim 29 words
A compound of claim 6, wherein R 1 is methyl, R 2 is phenul, furyl, or thienyl, and R 3 , R 4 and R 5 are each hydrogen.
Claim 9
Dependent Claim 11 words
A compound of claim 7, which is 1-methyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline or its hdrochloride.
Claim 10
Dependent Claim 23 words
A compound of claim 5, wherein R 2 is thienyl, R 3 is lower alkyl, R 4 and R 5 are each hydrogen.
Claim 11
Dependent Claim 33 words
A compound of claim 5, wherein R 2 is phenyl, R 3 is lowr alkenyl, lower alkanoyl having halogen or lower alkanoyl having piperidino, and R 4 and R 5 are each hydrogen.
Claim 12
Dependent Claim 12 words
A compound of claim 4, wherein n is an integer of 2.
Claim 13
Dependent Claim 26 words
A compound of claim 11, wherein R 1 is lower alkyl, R 2 is phenyl, R 3 , R 4 and R 5 are each hydrogen.
Claim 14
Dependent Claim 32 words
An N-methyl-D-aspartate receptor antagonist A pharmaceutical composition comprising an effective amount of a compound of claim 1, as an active ingredient, in association with a pharmaceutically acceptable, substantially nontoxic carrier or excipient.
Claim 15
Dependent Claim 30 words
A method for the therapeutic treatmetn of convulsion and delayed neuronal death which comprises administering an effective amount of a compound of claim 1 to a human being or animal.

References Cited (Backward Citations)

US3963725A Cited
US3978063A Cited
EP0230871A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-10-21 1995-04-22 1995-10-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-10-21 1999-04-22 1999-10-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-10-21 2003-04-22 2003-10-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag